These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 5404008)

  • 1. Effect of reserpine on accumulation and removal of d-amphetamine- 3 H.
    Stolk JM; Rech RH
    Biochem Pharmacol; 1969 Oct; 18(10):2786-8. PubMed ID: 5404008
    [No Abstract]   [Full Text] [Related]  

  • 2. Interaction of fenfluramine with d-amphetamine-induced excitatory behaviour and hyperthermia.
    Jonsson J; Gunne LM
    Eur J Pharmacol; 1972 Jul; 19(1):52-5. PubMed ID: 5048662
    [No Abstract]   [Full Text] [Related]  

  • 3. The effect of CNS catecholamine-depleting drugs on dextroamphetamine-induced elevation of halothane MAC.
    Johnston RR; Way WL; Miller RD
    Anesthesiology; 1974 Jul; 41(1):57-61. PubMed ID: 4275974
    [No Abstract]   [Full Text] [Related]  

  • 4. A daily rhythm in the rate of depletion of brain norepinephrine by reserpine.
    Black IB; Parker L; Axelrod J
    Biochem Pharmacol; 1969 Oct; 18(10):2688-91. PubMed ID: 5404003
    [No Abstract]   [Full Text] [Related]  

  • 5. Brain to serum distribution of radioactivity of injected ( 3 H)-d-amphetamine in differentially housed mice.
    DeFeudis FV; Marks JH
    Biol Psychiatry; 1973 Feb; 6(1):85-8. PubMed ID: 4710778
    [No Abstract]   [Full Text] [Related]  

  • 6. Enhanced stimulant effects of d-amphetamine on the spontaneous locomotor activity of rats treated with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1967 Oct; 158(1):140-9. PubMed ID: 6054074
    [No Abstract]   [Full Text] [Related]  

  • 7. Reserpine attenuates D-amphetamine and MDMA-induced transmitter release in vivo: a consideration of dose, core temperature and dopamine synthesis.
    Sabol KE; Seiden LS
    Brain Res; 1998 Sep; 806(1):69-78. PubMed ID: 9739110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Blockade by reserpine of methylphenidate-induced release of brain dopamine.
    Chiueh CC; Moore KE
    J Pharmacol Exp Ther; 1975 May; 193(2):559-63. PubMed ID: 1142104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced stimulant effects of d-amphetamine in rats treated chronically with reserpine.
    Stolk JM; Rech RH
    J Pharmacol Exp Ther; 1968 Sep; 163(1):75-83. PubMed ID: 5673717
    [No Abstract]   [Full Text] [Related]  

  • 10. A reassessment of the mechanism of reserpine-produced sedation.
    Millard SA; Gál EM
    Biol Psychiatry; 1969 Jul; 1(3):219-25. PubMed ID: 5352653
    [No Abstract]   [Full Text] [Related]  

  • 11. Enhanced stimulant properties of (+)-amphetamine after chronic reserpine treatment in the rat: mediation by hypophagia and weight loss.
    Fibiger HC; Trimbach C; Campbell BA
    Neuropharmacology; 1972 Jan; 11(1):57-67. PubMed ID: 5060518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Reserpine potentiation of a d-amphetamine effect].
    Boissier JR; Lwoff JM; Simon P
    Act Nerv Super (Praha); 1967 May; 9(2):160-2. PubMed ID: 6038244
    [No Abstract]   [Full Text] [Related]  

  • 13. Demonstration of reduced levels of zinc in rat brain after treatment with d-amphetamine, but not after treatment with reserpine.
    Szerdahelyi P; Kása P
    Histochemistry; 1985; 83(2):181-7. PubMed ID: 4044304
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences between the effects of acute and long-term treatment with desmethylimipramine on reserpine-induced release of amines from rat brain.
    Roffler-Tarlov S
    Biochem Pharmacol; 1975 Jul; 24(13-14):1321-5. PubMed ID: 1148020
    [No Abstract]   [Full Text] [Related]  

  • 15. The occurrence of tryptamine in rat brain and its pharmacological manipulation.
    Horn AS; Snodgrass SR
    Br J Pharmacol; 1973 Mar; 47(3):646P. PubMed ID: 4147196
    [No Abstract]   [Full Text] [Related]  

  • 16. The effects of D-amphetamine and related drugs on colonic temperatures of rats kept at various ambient temperatures.
    Yehuda S; Wurtman RJ
    Life Sci I; 1972 Sep; 11(18):851-9. PubMed ID: 4656106
    [No Abstract]   [Full Text] [Related]  

  • 17. Effects of catecholamine depleting drugs and d-amphetamine on self-stimulation of the substantia nigra and locus coeruleus.
    Cooper BR; Konkol RJ; Breese GR
    J Pharmacol Exp Ther; 1978 Mar; 204(3):592-605. PubMed ID: 24729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increase of brain tryptophan caused by drugs which stimulate serotonin synthesis.
    Tagliamonte A; Tagliamonte P; Perez-Cruet J; Gessa GL
    Nat New Biol; 1971 Jan; 229(4):125-6. PubMed ID: 4326812
    [No Abstract]   [Full Text] [Related]  

  • 19. ANTAGONISM OF RESERPINE BEHAVIORAL DEPRESSION BY D-AMPHETAMINE.
    RECH RH
    J Pharmacol Exp Ther; 1964 Dec; 146():369-76. PubMed ID: 14254332
    [No Abstract]   [Full Text] [Related]  

  • 20. A neuronal basis for the alerting action of (+)-amphetamine.
    Boakes RJ; Bradley PB; Candy JM
    Br J Pharmacol; 1972 Jul; 45(3):391-403. PubMed ID: 5072225
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.